risperidone has been researched along with MS (Multiple Sclerosis) in 7 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of risperidone-induced Pisa syndrome in a patient with multiple sclerosis (MS) that resolved with lurasidone, recurred with chlorpromazine, and was complicated by possible drug-drug interactions." | 7.79 | Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine. ( Diefenderfer, LA; Iuppa, CA, 2013) |
| " Given the potential of these drugs to modulate the immune system both peripherally and within the central nervous system, we investigated the ability of the atypical anti-psychotic agent, risperidone, to modify disease in the animal model of multiple sclerosis (MS)4, experimental autoimune encephalomyelitis (EAE)." | 3.80 | Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis. ( Connor, B; Fong, D; Green, L; Kharkrang, M; La Flamme, AC; O'Sullivan, D; Stone, S; Zareie, P, 2014) |
| "To report a case of risperidone-induced Pisa syndrome in a patient with multiple sclerosis (MS) that resolved with lurasidone, recurred with chlorpromazine, and was complicated by possible drug-drug interactions." | 3.79 | Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine. ( Diefenderfer, LA; Iuppa, CA, 2013) |
| "Cuprizone and drugs were administered to C57BL6/J mice for five weeks and locomotor activity, motor performance and cold sensitivity were assessed." | 1.62 | Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress. ( Andrei, C; Chirita, C; Ciotu, CI; Fischer, MJM; Mihai, DP; Negres, S; Nitulescu, GM; Olaru, OT; Seremet, OC; Ungurianu, A; Zanfirescu, A; Zbarcea, CE, 2021) |
| "Risperidone was given for ongoing delusions." | 1.56 | Manic episode in patient with bipolar disorder and recent multiple sclerosis diagnosis: A case report. ( Wichser, L; Yang, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, S | 1 |
| Wichser, L | 1 |
| Mihai, DP | 1 |
| Ungurianu, A | 1 |
| Ciotu, CI | 1 |
| Fischer, MJM | 1 |
| Olaru, OT | 1 |
| Nitulescu, GM | 1 |
| Andrei, C | 1 |
| Zbarcea, CE | 1 |
| Zanfirescu, A | 1 |
| Seremet, OC | 1 |
| Chirita, C | 1 |
| Negres, S | 1 |
| Iuppa, CA | 1 |
| Diefenderfer, LA | 1 |
| O'Sullivan, D | 1 |
| Green, L | 1 |
| Stone, S | 1 |
| Zareie, P | 1 |
| Kharkrang, M | 1 |
| Fong, D | 1 |
| Connor, B | 1 |
| La Flamme, AC | 1 |
| Espinosa, PS | 1 |
| Berger, JR | 1 |
| Reiss, JP | 1 |
| Sam, D | 1 |
| Sareen, J | 1 |
| Hussain, A | 1 |
| Belderbos, S | 1 |
7 other studies available for risperidone and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Manic episode in patient with bipolar disorder and recent multiple sclerosis diagnosis: A case report.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium Compounds; Middle | 2020 |
Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress.
Topics: Animals; Corpus Callosum; Cuprizone; Disease Models, Animal; Drug Evaluation, Preclinical; Febuxosta | 2021 |
Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
Topics: Adult; Antipsychotic Agents; Child Development Disorders, Pervasive; Chlorpromazine; Gait Ataxia; Hu | 2013 |
Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis.
Topics: Animals; Antigens; Antipsychotic Agents; Cell Survival; Cytokines; Disease Models, Animal; Dose-Resp | 2014 |
Delayed fingolimod-associated asystole.
Topics: Administration, Oral; Antipsychotic Agents; Bradycardia; Electrocardiography; Fingolimod Hydrochlori | 2011 |
Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delusions; Excitatory Amino Acid Antagonists; Female; | 2006 |
Risperidone depot in the treatment of psychosis associated with multiple sclerosis -- a case report.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Female; Humans; Middle Aged; Multiple Sclerosis; | 2008 |